课题基金 / 基金详情

The concurrent use of medications with opposing actions: the prevalence and impact of prescribing both anticholinergics and cholinesterase inhibitors to people with dementia

The concurrent use of medications with opposing actions: the prevalence and impact of prescribing both anticholinergics and cholinesterase inhibitors to people with dementia
同时使用具有相反作用的药物：对痴呆症患者同时使用抗胆碱能药物和胆碱酯酶抑制剂的患病率和影响
批准号：
172688
负责人：
Gill Sudeep S
金额：
$9.07万
依托单位：
Queen's University (Kingston, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2008
资助国家：
加拿大
项目状态：
已结题
起止时间：
2008-09-01 至 2011-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=172688&lang=en
关键词：
Administrative Health Care Databases Adverse Drug Events Clinical Pharmacology Geriatrics Nested Case-Control Study Pharmacoepidemiology

项目摘要

项目成果

Gill Sudeep S的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A wide variety of medications possess anticholinergic properties, meaning they block a chemical called acetylcholine in the body. The anticholinergic effects of these drugs can be especially concerning in older adults for several reasons. First, they can
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The concurrent use of medications with opposing actions: the prevalence and impact of prescribing both anticholinergics and cholinesterase inhibitors to people with dementia
海外基金